NovaBay Pharmaceuticals Launches DERMAdoctor’s New Comfort + Joy Psoriasis Therapeutic Moisturizing Cream on the QVC® Network
April 21 2023 - 6:50AM
Business Wire
First DERMAdoctor product specifically
formulated for psoriasis will be exclusively available on Jane
& Shawn’s Beauty Secrets tonight at 10 p.m. Eastern time
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a company
developing and commercializing high-quality eyecare, skincare and
wound care products, announces that Chief Product Officer and
board-certified dermatologist Audrey Kunin, MD will introduce the
new DERMAdoctor Comfort + Joy Psoriasis Therapeutic Moisturizing
Cream with 3% Salicylic Acid as an on-air guest on the QVC network.
The new product for the treatment and relief of symptoms of
psoriasis will be featured on Jane & Shawn’s Beauty Secrets
tonight at 10 p.m. Eastern time.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230421005008/en/
DERMAdoctor® Psoriasis Therapeutic
Moisturizing Cream with 3% Salicylic Acid (Photo: Business
Wire)
Psoriasis Therapeutic Moisturizing Cream with 3% Salicylic Acid
will be available exclusively on QVC through a special offer of two
8 fluid ounce size tubes for $52. This product will be available on
DERMAdoctor.com and Amazon for $46 for a single tube beginning July
31, 2023.
“Psoriasis afflicts about 125 million people worldwide and
nearly 8 million in the U.S., with more than half reporting that
psoriasis is a significant problem in their everyday life,” said
Dr. Kunin. “We are thrilled to introduce our first specially
formulated product to provide relief from the itching, scaling,
redness, flaking and irritation caused by psoriasis on QVC. Our new
luxe moisturizing cream contains salicylic acid to relieve and
prevent the recurrence of psoriasis symptoms, while helping to
restore skin’s essential moisture for a soft, supple, comfortable
and joy-filled appearance.”
Psoriasis Therapeutic Moisturizing Cream with 3% Salicylic Acid
delivers a sophisticated blend of maximum-strength salicylic acid –
the active ingredient that helps control the symptoms of psoriasis
and provides relief from itching, irritation and redness – together
with ceramides to help protect and preserve the skin barrier to
keep in vital moisture, hyaluronic acid to draw moisture from the
air to keep skin feeling plump and hydrated, and squalene to help
moisturize skin. Steroid-free and fragrance-free, this clean
formulation is appropriate for even the most sensitive skin from
head to toe.
Dr. Kunin is an author, clinician, educator, television
personality and recognized trailblazer in the skincare industry.
DERMAdoctor products are scientifically formulated to provide
measurable results for common skincare concerns that have been
overlooked by the beauty industry. DERMAdoctor delivers on the
promise that clinical skin therapy can be simple and easy. All
DERMAdoctor products are scientifically formulated to provide
measurable results for common skincare concerns that have been
largely overlooked by the beauty industry and are hypoallergenic,
non-irritating, non-drying, pH balanced and free of synthetic
fragrance and dyes.
About Psoriasis
Psoriasis is an immune-mediated condition that causes the body
to make new skin cells in days rather than weeks. Anyone can get
this disease, regardless of age; however, it often has two peaks of
onset with the first between age 20-30 and the second between age
50-60. Males and females get it at about the same rate. Psoriasis
can show up anywhere on the body including eyelids, ears, mouth,
lips, skin folds, hands, feet and nails.
About NovaBay Pharmaceuticals, Inc.:
NovaBay Pharmaceuticals, Inc. develops and sells scientifically
created and clinically proven eyecare and skincare products.
NovaBay’s leading product, Avenova® Antimicrobial Lid & Lash
Solution, is often prescribed by eyecare professionals for
blepharitis and dry-eye disease and is also available directly to
eyecare consumers through online distribution channels such as
Amazon. DERMAdoctor® offers more than 30 OTC
dermatologist-developed skincare products through the DERMAdoctor
website, well-known traditional and digital beauty retailers, and
international distributors. NovaBay also manufactures and sells
effective, yet gentle and non-irritating wound care products. The
PhaseOne® brand is distributed through commercial partners in the
U.S. for professional use only, and the NeutroPhase® brand is
distributed in China by Pioneer Pharma (Hong Kong) Company Ltd.
NovaBay Pharmaceuticals Forward-Looking Statements
Except for historical information herein, matters set forth in
this press release may be forward looking within the meaning of the
“safe harbor” provisions of the Private Securities Litigation
Reform Act of 1995, including statements about the commercial
progress and future financial performance of NovaBay
Pharmaceuticals, Inc. This release contains forward-looking
statements that are based upon management’s current expectations,
assumptions, estimates, projections and beliefs. These statements
include, but are not limited to, statements regarding our business
strategies, current partnerships, marketing efforts, and any future
revenue that may result from such partnerships and related
marketing initiatives, as well as generally the Company’s expected
future financial results. These statements involve known and
unknown risks, uncertainties and other factors that may cause
actual results or achievements to be materially different and
adverse from those expressed in or implied by the forward-looking
statements. Factors that might cause or contribute to such
differences include, but are not limited to, risks and
uncertainties relating to the size of the potential market for our
products, the possibility that the available market for the
Company’s products will not be as large as expected, the Company’s
products will not be able to penetrate one or more targeted
markets, and revenues will not be sufficient to meet the Company’s
cash needs. Other risks relating to NovaBay’s business, including
risks that could cause results to differ materially from those
projected in the forward-looking statements in this press release,
are detailed in NovaBay’s latest Form 10-Q/K filings and
Registration Statement on Form S-1 filing with the Securities and
Exchange Commission, especially under the heading “Risk Factors.”
The forward-looking statements in this release speak only as of
this date, and NovaBay disclaims any intent or obligation to revise
or update publicly any forward-looking statement except as required
by law.
Socialize and Stay Informed on
NovaBay’s Progress Like us on Facebook Follow us on
Twitter Connect with NovaBay on LinkedIn Visit NovaBay’s
Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230421005008/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Apr 2023 to Apr 2024